Simplify Logo

Full-Time

Director of Business Development

Confirmed live in the last 24 hours

Formation Bio

Formation Bio

51-200 employees

Hardware
AI & Machine Learning
Biotechnology
Healthcare

Compensation Overview

$195k - $250kAnnually

+ Equity + Perks + Location Flexibility + Comprehensive Benefits

Mid, Senior

New York, NY, USA

Category
Business Development
Business & Strategy
Requirements
  • Either an MBA or graduate degree in biological sciences
  • 4+ years non-academic work experience in analyzing biotech companies – ideally in business development roles at pharmaceutical companies or on the buy-side at a venture capital or private investment firm
  • Experience with licensing transactions, term sheet negotiations, and partnerships across the biopharma industry
  • Proficiency with financial statement analysis, accounting and financial modeling
  • Strong track record in sourcing, negotiating and closing transactions, with a high degree of diplomacy and empathic awareness
  • Advanced ability creating decks to correspond meeting
Responsibilities
  • In coordination with the executive leadership of Formation Bio, lead the assessment of science, clinical development plans, regulatory outlook, commercial opportunities, intellectual property, competitive landscape and valuation analysis to help determine the overall attractiveness of potential investment and asset licensing opportunities
  • Conduct due diligence calls with physicians, scientists, and other subject matter experts (consultants) and build therapeutic market and financial models to support investment recommendations
  • Prepare and present investment materials and supporting documentation associated with potential investments
  • Attend scientific, business development and broker conferences to identify investment and asset licensing opportunities
  • Lead idea generation and develop thematic investment strategies to identify areas where Formation Bio can unlock additional value using our clinical development engine
  • Assist in operations and other *ad hoc* tasks to support portfolio management
  • Mentor junior team members

Company Stage

Series D

Total Funding

$515.8M

Headquarters

New York City, New York

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

6%

2 year growth

25%
Simplify Jobs

Simplify's Take

What believers are saying

  • The recent $372M Series D funding will significantly bolster Formation Bio's expansion and product development efforts.
  • Collaborations with industry leaders like Sanofi and OpenAI could revolutionize drug discovery and development, enhancing the company's market position.
  • Formation Bio's innovative approach to clinical trials promises more efficient and faster drug development, potentially leading to quicker market entry and higher revenue.

What critics are saying

  • The high dependency on AI and technology platforms may pose risks if these technologies fail to deliver as expected.
  • The competitive nature of the pharmaceutical industry means that Formation Bio must continuously innovate to maintain its edge.

What makes Formation Bio unique

  • Formation Bio leverages a tech-driven platform to optimize clinical drug development, unlike traditional pharmaceutical companies that rely on conventional methods.
  • Their strategic partnerships with AI leaders like OpenAI and pharmaceutical giants such as Sanofi set them apart in the competitive landscape.
  • Formation Bio's focus on acquiring and accelerating the development of clinical-stage drugs enables faster access to new treatments for patients.